Comparative trial of pantoprazole and ranitidine in the treatment of reflux esophagitis: Results of a german multicenter study

Journal of Clinical Gastroenterology

Volumn 20, Issue 3, 1995, Pages 192-195

  Koop, Herbert ^d   Schepp, Wolfgang ^a   Dammann, Hans G ^b   Schneider, Andreas ^c   Lühmann, Reinhold ^c   Classen, Meinhard ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b Krankenhaus Bethanien   (Germany)

^c ALTANA PHARMA AG   (Germany)

^d NONE

Author keywords

Esophagitis; Gastroesophageal reflux; H2 receptor antagonists; Pantoprazole; Ranitidine

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST; PANTOPRAZOLE; PROTON PUMP INHIBITOR; RANITIDINE;

ABDOMINAL PAIN; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SCREENING; FEMALE; HEADACHE; HEARTBURN; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; REFLUX ESOPHAGITIS; VERTIGO;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; BENZIMIDAZOLES; DOUBLE-BLIND METHOD; ESOPHAGITIS, PEPTIC; FEMALE; H(+)-K(+)-EXCHANGING ATPASE; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; RANITIDINE; SULFOXIDES;

EID: 0028964575     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/00004836-199504000-00005     Document Type: Article

References (16)

1. Simon WA, Büdingen C, Fahr S, Kinder B, Koske M. The H+, K+-ATPase inhibitor pantoprazole (BY1023/SK&F96022) interacts less with cytochrome P 450 than omeprazole and lan-soprazole. Biochem Pharmacol 1991;42:347-55.
2. +-ATPase. Biochim Biophys Acta Bio Membr 1993;1148:223-33.
3. Simon B, Müller P, Marinis E, Lühmann R, Huber R, Hartmann M, Wurst W Effect of repeated oral administration of BY 1023/SK&F 96022 - a new substituted benzimidazole derivative-on pentagastrin stimulated gastric acid secretion and pharmacokinetics in man. Aliment Pharmacol Ther 1990; 4:373-9.
4. Hartmann M, Theiß U, Bliesath H, Kuhn I, Lühmann R, Huber R, Wurst W, Postius S, Lücker P. 24-h intragastric pH following oral intake of pantoprazole and omeprazole. Hellenic J Gastroenterol 1992;5(suppl 2):113.
5. Savery M, Miller G. The oesophagus. Solothurn: Gassmann, 1977.
6. Reference deleted in proofs.
7. Klinkenberg-Knol EC, Jansen JMB, Festen HPM, Meuwissen SGM, Lamers CBHW. Double-blind multicentre comparison of omeprazole and ranitidine in the treatment of reflux esopha-gitis. Lancet 1987;i:349-51.
8. Zeitoun P, Rampai P, Barbier P, Isal JP, Ericksson E, Carlsson R. Omeprazole versus ranitidine in the treatment of reflux esopha-gitis: results of a randomized, double-blind, multicentre French-Belgian Study. Gastroenterol Clin Biol 1989;13:457-62.
9. Sandmark S, Carlsson R, Fausa O, Lundeli L. Omeprazole or ranitidine in the treatment of reflux esophagitis: results of a double-blind, randomized, Scandinavian multicenter study. Scand J Gastroenterol 1988;23:625-32.
10. Vantrappen G, Rutgeerts L, Schurmans P, Coenegracht JL. Omeprazole (40 mg) is superior to ranitidine in short-term treatment of ulcerative reflux esophagitis. DigDisSci 1988;33:523-9.
11. Hetzel DJ, Dent J, Reed WD, Narielvala FM, Mackinnon M, McCarthy JH, et al. Healing and relapse of severe peptic esophagitis after treatment with omeprazole. Gastroenterology 1988; 95:903-12.
12. Sontag SJ, Hirschowitz BI, Holt S, et al. Two doses of omeprazole versus placebo in symptomatic erosive esophagitis: the U.S. multicenter study. Gastroenterology 1992; 102:109-18.
13. Müller P, Simon B, Khalil H, Lühmann R, Leucht U, Schneider A. Dose-range finding study with the proton pump inhibitor pantoprazole in acute duodenal ulcer patients. Z Gastroenterol 1992;30:771-5.
14. Hatlebakk JG, Berstad A, Carling L, Svedberg LE, Unge P, Ekström P, et al. Lansoprazole versus omeprazole in short-term treatment of reflux esophagitis: results from a Scandinavian multi-centre trial. Scand J Gastroenterol 1993;28:224-8.
15. Dammann HG, Blum AL, Lux G, et al. Unterschiedliche Heilungstendenz der Refluxösophagitis nach Omeprazol und Ranitidin. Dtsch Med Wochenschr 1986;lll:123-8.
16. Sonnenberg A. Geographic and temporal variations of the occurrence of peptic ulcer disease. Scand J Gastroenterol 1985;20(suppl 110):11-24.